Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial DNA (mtDNA) replication machinery, also known as the mitochondrial replisome, is a specialized protein complex responsible for the duplication and maintenance of the mitochondrial genome (PMID: 16352715). The core components of this machinery include the heterotrimeric DNA polymerase gamma (POLG), the hexameric Twinkle DNA helicase (TWNK), and the mitochondrial single-stranded DNA-binding protein (SSBP1) (UniProt: P54098, Q96RR1, Q04837). This system is essential for cellular energy production, as mtDNA encodes 13 critical subunits of the oxidative phosphorylation system (PMID: 27694354). While not typically a primary therapeutic target for activation, it is a major site of off-target toxicity for nucleoside reverse transcriptase inhibitors (NRTIs) used in HIV treatment, which can inhibit POLG and lead to mtDNA depletion (PMID: 11478370). Emerging research also explores the intentional inhibition of this machinery as a strategy to treat certain cancers that exhibit high dependency on mitochondrial function (PMID: 30143515). Mutations in the genes encoding these proteins are linked to a spectrum of mitochondrial diseases, such as Alpers-Huttenlocher syndrome and progressive external ophthalmoplegia (PMID: 15505000).
Inhibition of DNA polymerase gamma (POLG) by nucleoside analogs, leading to DNA chain termination and depletion of mitochondrial DNA (PMID: 16352715).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial DNA replication machinery (mtDNA replication machinery).